Navigation Links
Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
Date:2/27/2013

SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin , Chief Financial Officer of Neurocrine Biosciences, will be presenting at the Cowen and Company 33rd Annual Health Care Conference in Boston.  

The live presentation takes place on Wednesday, March 6 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
2. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
3. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
4. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
5. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
8. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
9. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
10. Neurocrine Biosciences Reports First Quarter 2012 Results
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... and PUNE, India , February 22, 2017 ... global market was valued at $3,453 million in 2015 and is projected to reach ... The arthroscopic implants segment held nearly two-fifths of the total market in 2015. ... ... Research Logo ...
(Date:2/22/2017)... Feb. 22, 2017   Protein Sciences Corporation , ... Flublok® Influenza Vaccine , announced today that they donated ... Vaccine Introduction (PIVI) and the Mongolian Ministry of Health ... the flu.  The doses of Flublok have been distributed ... for health care workers, pregnant women, and ...
(Date:2/22/2017)... MIAMI , Feb. 22, 2017  Tri-Source Pharma ... restructuring efforts. A series of newly appointed positions were ... founder and CEO, Robert DiCrisci , in the ... plan and management of the recently consolidated subsidiary companies. ... Tri-Source,s executive team will be composed of the following ...
Breaking Medicine Technology:
(Date:2/22/2017)... Singapore, Singapore (PRWEB) , ... February 22, 2017 , ... ... high-end medical leads utilizing a simple online checklist. Over a period of just 24 ... with the assistance of an online checklist called T.A.D. , “The internet is not ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus ... the latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems ... pain management, to accelerate tissue synthesis and provide a faster and more efficient ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the Athens Home Show with ... , A shift from Super-Sod’s simple Athens Home Show booth of 2016, this year’s ... seed plant manager Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod ...
(Date:2/22/2017)... ... February 22, 2017 , ... In today’s world, homeowners face ... the market, it is easy to start feeling frustrated and confused. To help ... complimentary security consultation. , Home Security Hardware Choices, There are innumerable choices for ...
(Date:2/21/2017)... ... ... Author Michèle Wolff has a passion for using food as medicine ... about it for optimal health. Wanting to share her knowledge to the world, she ... Solutions ” (published by Balboa Press AU). , This book inspires readers to ...
Breaking Medicine News(10 mins):